Estrogen-related receptor α expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma

Cancer Research

Volumn 69, Issue 12, 2009, Pages 5186-5193

  Heck, Stefanie ^a   Rom, Joachim ^a   Thewes, Verena ^a   Becker, Natalia ^a   Blume, Beatrix ^b   Sinn, Hans Peter ^a   Deuschle, Ulrich ^b   Sohn, Christof ^a   Schneeweiss, Andreas ^a   Lichter, Peter ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PHENEX PHARMACEUTICALS AG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR ALPHA; MESSENGER RNA; STEROID RECEPTOR COACTIVATOR 3;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CANCER RESISTANCE; CANCER TISSUE; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARKER GENE; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE; TRANSCRIPTION INITIATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; FLUORESCENCE RESONANCE ENERGY TRANSFER; HISTONE ACETYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 67449127093     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3062     Document Type: Article

References (42)

1. Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004;51:55-67. (Pubitemid 38781751)
2. Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2003;2:205-213
3. Normanno N, Di Maio M, De Maio E, et al. Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer. Endocr Relat Cancer 2005;12:721-747 (Pubitemid 41815773)
4. Rochefort H, Glondu M, Sahla ME, Platet N, Garcia M. How to target estrogen receptor-negative breast cancer? Endocr Relat Cancer 2003;10:261-266
5. Stein RA, McDonnell DP. Estrogen-related receptor α as a therapeutic target in cancer. Endocr Relat Cancer 2006;13 Suppl 1:S25-S32. (Pubitemid 46219246)
6. Ariazi EA, Jordan VC. Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem 2006;6:203-215
7. Suzuki T, Miki Y, Moriya T, et al. Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor. Cancer Res 2004;64:4670-4676 (Pubitemid 38856942)
8. Ariazi EA, Clark GM, Mertz JE. Estrogen-related receptor α and estrogen-related receptor γ associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 2002;62:6510-6518 (Pubitemid 35364116)
9. Stein RA, Chang CY, Kazmin DA, et al. Estrogen-related receptor α is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res 2008;68:8805-8812
10. Tremblay AM, Giguère V. The NR3B subgroup: an ovERRview. Nucl Recept Signal 2007;5:e009.
11. Kraus RJ, Ariazi EA, Farrell ML, Mertz JE. Estrogen-related receptor α1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells. J Biol Chem 2002;277:24826-24834 (Pubitemid 34952015)
12. Lu D, Kiriyama Y, Lee KY, Giguere V. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res 2001;61:6755-6761 (Pubitemid 32898670)
13. Yang C, Zhou D, Chen S. Modulation of aromatase expression in the breast tissue by ERR α-1 orphan receptor. Cancer Res 1998;58:5695-5700 (Pubitemid 29006408)
14. Horard B, Vanacker JM. Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J Mol Endocrinol 2003;31:349-357 (Pubitemid 38054510)
15. Barry JB, Giguere V. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor α. Cancer Res 2005;65:6120-6129 (Pubitemid 40994397)
16. Ariazi EA, Kraus RJ, Farrell ML, Jordan VC, Mertz JE. Estrogen-related receptor α1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway. Mol Cancer Res 2007;5:71-85. (Pubitemid 46246768)
17. Tremblay GB, Kunath T, Bergeron D, et al. Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERRβ. Genes Dev 2001;15:833-838 (Pubitemid 32295064)
18. Coward P, Lee D, Hull MV, Lehmann JM. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor γ. Proc Natl Acad Sci U S A 2001;98:8880-8884 (Pubitemid 32678121)
19. Busch BB, Stevens WC, Martin R, et al. Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor α. J Med Chem 2004;47:5593-5596 (Pubitemid 39447252)
20. Willy PJ, Murray IR, Qian J. Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand. Proc Natl Acad Sci U S A 2004;101:8912-8917 (Pubitemid 38781585)
21. Stein R, Way JM, McDonnell DP, Zuercher WJ. Estrogen-related receptor a as a therapeutic target. Drugs Fut 2006;31:427-436 (Pubitemid 44113415)
22. Xie W, Hong H, Yang NN, et al. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Mol Endocrinol 1999;13:2151-2162 (Pubitemid 30637273)
23. Yan J, Tsai SY, Tsai MJ. SRC-3/AIB1: transcriptional coactivator in oncogenesis. Acta Pharmacol Sin 2006;27:387-394
24. Liao L, Kuang SQ, Yuan Y, Gonzalez SM, O'Malley BW, Xu J. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. J Steroid Biochem Mol Biol 2002;83:3-14. (Pubitemid 37040636)
25. Fleming FJ, Myers E, Kelly G, et al. Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. J Clin Pathol 2004;57:1069-1074 (Pubitemid 39331358)
26. Zhang Z, Yamashita H, Toyama T, et al. NCOR1 mRNA is an independent prognostic factor for breast cancer. Cancer Lett 2006;237:123-129
27. Pscherer A, Schliwka J, Wildenberger K, et al. Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma. FASEB J 2006;20:1188-1190 (Pubitemid 44943867)
28. Aulmann S, Adler N, Rom J, Helmchen B, Schirmacher P, Sinn HP. c-myc amplifications in primary breast carcinomas and their local recurrences. J Clin Pathol 2006;59:424-428
29. Remmele W, Stegner HE. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987;8:138-140
30. Suzuki R, Shimodaira H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 2006;22:1540-1542 (Pubitemid 43985330)
31. Albers M, Blume B, Schlueter T, et al. A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors. J Biol Chem 2006;281:4920-4930 (Pubitemid 43847754)
32. Dyer BW, Ferrer FA, Klinedinst DK, Rodriguez R. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 2000;282:158-161 (Pubitemid 30409441)
33. Liu D, Zhang Z, Gladwell W, Teng CT. Estrogen stimulates estrogen-related receptor α gene expression through conserved hormone response elements. Endocrinology 2003;144:4894-4904 (Pubitemid 37378404)
34. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S, Sonoo H. Expression levels of estrogen receptor-α, estrogen receptor-β, co-activators, and co-repressors in breast cancer. Clin Cancer Res 2000;6:512-518 (Pubitemid 30111472)
35. Watkins G, Douglas-Jones A, Mansel RE, Jiang WG. The localisation and reduction of nuclear staining of PPARγ and PGC-1 in human breast cancer. Oncol Rep 2004;12:483-488
36. Torres-Arzayus MI, Font de Mora J, Yuan J, et al. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 2004;6:263-274 (Pubitemid 39222039)
37. Anzick SL, Kononen J, Walker RL, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997;277:965-968 (Pubitemid 27366683)
38. List HJ, Reiter R, Singh B, Wellstein A, Riegel AT. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. Breast Cancer Res Treat 2001;68:21-28 (Pubitemid 32928267)
39. Girault I, Bièche I, Lidereau R. Role of estrogen receptor α transcriptional coregulators in tamoxifen resistance in breast cancer. Maturitas 2006;54:342-351
40. Osborne CK, Osborne CK, Bardou V, et al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and Her-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 2003;95:353-361 (Pubitemid 36395255)
41. Bouras T, Southey MC, Venter DJ. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 2001;61:903-907 (Pubitemid 32174400)
42. Kallen J, Lattmann R, Beerli R, et al. Crystal structure of human estrogen-related receptor α in complex with a synthetic inverse agonist reveals its novel molecular mechanism. J Biol Chem 2007;282:23231-23239 (Pubitemid 47311915)